Literature DB >> 26634587

EXHALED BREATH TEMPERATURE IN ASTHMATIC CHILDREN.

S Leonardi1, C Cuppari2, A Lanzafame1, D Attardo1, L Tardino1, G Parisi1, V Giacchi1, S Manti2, T Arrigo2.   

Abstract

Asthma is characterized by chronic inflammation of airways. Currently, no traditional method allows an easy daily evaluation of the degree of airway inflammation. Measuring inflammatory biomarkers in the breath is a very attractive approach to monitor asthma inflammation. In recent years, the measurement of exhaled breath temperature (EBT) has been proposed as a method capable of detecting the inflammatory status of the airways. The objective of this study is to strengthen the role of EBT in the diagnosis and monitoring of asthma. The study sample was represented by a group of 40 patients, of both sexes, aged 6-15 years. The elective criteria for submitting patients to EBT determination were abstaining from drugs in the preceding 24 h, fasting for at least 2 h, physical resting for at least 30 minutes, a body temperature between 35-37°C. The temperature in the room of the surveys ranged from 18 to 25°C. The EBT values of asthmatic patients were higher [(median (IQR): 29.77°C (30.67°C to 29.38°C) range 28.46°C min-max 34.78°C] than those of non-asthmatic ones (median (IQR): 28.22°C (29.09°C-27.7°C), range 27.09°C min-max 30.07°C] and this difference was highly significant (p less than 0.001). Furthermore, no significant difference was found between the EBT values of the following groups of patients: those exposed and not exposed to passive smoking, those receiving and not receiving leukotriene drugs, those receiving and not receiving specific immunotherapy, monoallergic patients and poliallergic ones, those sensitized and not sensitized to house dust, perennial allergic patients and seasonal allergic ones. In addition, the evaluation of the correlation of EBT values with body temperature (r=0.119, p=0.464) and ambient temperature (r=-304, p = 0.057) did not show any significant correlation. Finally, no statistically significant correlation was demonstrated between EBT values and FEV1 (r=-0055, p=0.81, Fig. 4). In conclusion, the data of the present study further support the hypothesis that EBT can be considered a good method for monitoring asthma.

Entities:  

Year:  2015        PMID: 26634587

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  8 in total

1.  [Predictive significance of exhaled breath temperature for airway inflammation changes in children with asthma].

Authors:  Hou-Lan Xiao; Zhen-Hua Chen; Dong-Wu Zhang; Xu-Hong Xie
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-08

2.  Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: a pilot study.

Authors:  Maria Papale; Giuseppe Parisi; Lucia Spicuzza; Novella Rotolo; Enza Mulè; Donatella Aloisio; Sara Manti; Salvatore Leonardi
Journal:  Acta Biomed       Date:  2021-05-12

Review 3.  An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases.

Authors:  Amelia Licari; Riccardo Castagnoli; Elisa Panfili; Alessia Marseglia; Ilaria Brambilla; Gian Luigi Marseglia
Journal:  Curr Respir Med Rev       Date:  2017-03

Review 4.  Measuring inflammation in paediatric severe asthma: biomarkers in clinical practice.

Authors:  Amelia Licari; Sara Manti; Riccardo Castagnoli; Salvatore Leonardi; Gian Luigi Marseglia
Journal:  Breathe (Sheff)       Date:  2020-03

5.  Minor pulmonary malformations in a child.

Authors:  Sara Manti; Giuseppe Fabio Parisi; Lucia Tardino; Mariaconcetta Cutrupi; Carmelo Salpietro; Caterina Cuppari; Oliviero Sacco; Salvatore Leonardi
Journal:  Breathe (Sheff)       Date:  2018-06

6.  Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls.

Authors:  Ellen Tufvesson; Erik Nilsson; Todor A Popov; Roger Hesselstrand; Leif Bjermer
Journal:  Eur Clin Respir J       Date:  2020-04-12

7.  Wheeze and cough measurements at night in children with respiratory symptoms.

Authors:  Markus Lindenhofer; Lena Roth; Clemens Mädel; Florian Götzinger; Katharina Kainz; Christiane Lex; Thomas Frischer; Matthias Reinweber; Angela Zacharasiewicz
Journal:  BMC Pediatr       Date:  2020-12-12       Impact factor: 2.125

8.  Predictive Value of Nasal Nitric Oxide and Serum NOS2 Levels in the Efficacy of Subcutaneous Immunotherapy in Pediatric Patients with Allergic Rhinitis.

Authors:  Sihui Wen; Shenghao Cheng; Shaobing Xie; Hua Zhang; Junyi Zhang; Fengjun Wang; Shumin Xie; Zhihai Xie; Weihong Jiang
Journal:  Mediators Inflamm       Date:  2022-08-16       Impact factor: 4.529

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.